NasdaqGS - Delayed Quote USD

ACADIA Pharmaceuticals Inc. (ACAD)

17.07 -0.12 (-0.70%)
At close: April 18 at 4:00 PM EDT
17.07 0.00 (0.00%)
After hours: April 18 at 7:13 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
726,437.00
726,437.00
517,235.00
484,145.00
441,755.00
Cost of Revenue
41,638.00
41,638.00
10,166.00
19,141.00
20,550.00
Gross Profit
684,799.00
684,799.00
507,069.00
465,004.00
421,205.00
Operating Expense
758,178.00
758,178.00
730,665.00
635,443.00
707,791.00
Operating Income
-73,379.00
-73,379.00
-223,596.00
-170,439.00
-286,586.00
Net Non Operating Interest Income Expense
17,234.00
17,234.00
6,610.00
591.00
6,610.00
Other Income Expense
5,109.00
5,109.00
3,542.00
2,329.00
-997.00
Pretax Income
-51,036.00
-51,036.00
-213,444.00
-167,519.00
-280,973.00
Tax Provision
10,250.00
10,250.00
2,531.00
351.00
611.00
Net Income Common Stockholders
-61,286.00
-61,286.00
-215,975.00
-167,870.00
-281,584.00
Diluted NI Available to Com Stockholders
-61,286.00
-61,286.00
-215,975.00
-167,870.00
-281,584.00
Basic EPS
-0.37
-0.37
-1.34
-1.05
-1.79
Diluted EPS
-0.37
-0.37
-1.34
-1.05
-1.79
Basic Average Shares
163,819.00
163,819.00
161,683.00
160,493.00
157,331.00
Diluted Average Shares
163,819.00
163,819.00
161,683.00
160,493.00
157,331.00
Total Operating Income as Reported
-73,379.00
-73,379.00
-223,596.00
-170,439.00
-286,586.00
Total Expenses
799,816.00
799,816.00
740,831.00
654,584.00
728,341.00
Net Income from Continuing & Discontinued Operation
-61,286.00
-61,286.00
-215,975.00
-167,870.00
-281,584.00
Normalized Income
-61,286.00
-61,286.00
-215,975.00
-167,870.00
-281,584.00
Interest Income
17,234.00
17,234.00
6,610.00
591.00
6,610.00
Net Interest Income
17,234.00
17,234.00
6,610.00
591.00
6,610.00
EBIT
-73,379.00
-73,379.00
-223,596.00
-170,439.00
-286,586.00
EBITDA
-67,827.00
-67,827.00
-221,570.00
-167,095.00
-283,654.00
Reconciled Cost of Revenue
41,638.00
41,638.00
10,166.00
19,141.00
20,550.00
Reconciled Depreciation
5,552.00
5,552.00
2,026.00
3,344.00
2,932.00
Net Income from Continuing Operation Net Minority Interest
-61,286.00
-61,286.00
-215,975.00
-167,870.00
-281,584.00
Normalized EBITDA
-67,827.00
-67,827.00
-221,570.00
-167,095.00
-283,654.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 5/27/2004
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

SAGE Sage Therapeutics, Inc.
13.04
+3.70%
 
INCY Incyte Corporation
52.82
+0.19%
 
RARE Ultragenyx Pharmaceutical Inc.
43.38
-1.65%
 
APLS Apellis Pharmaceuticals, Inc.
47.51
-1.08%
 
EXEL Exelixis, Inc.
22.49
-1.66%
 
BBIO BridgeBio Pharma, Inc.
24.95
-0.12%
 
BGNE BeiGene, Ltd.
131.96
+0.08%
 
BHVN Biohaven Ltd.
42.16
-4.25%
 
SRPT Sarepta Therapeutics, Inc.
116.55
-1.14%
 
BPMC Blueprint Medicines Corporation
88.90
+0.59%